screening

A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening;

A unique collection of 3170 approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2850 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 1490 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3660 drugs with anti-cancer activity or potential anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1220 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of 718 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of 1470 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A collection of 19730 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of 2073 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 535 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 1600 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 1440 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening;

A unique collection of 2400 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc.

A unique collection of 800 of cosmetic ingredient compounds.

A unique collection of 861 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

A unique collection of 755 nuclear receptor signaling targeted compounds for high throughput and high content screening;

Membrane proteins are a class of proteins widely found in biological cell membranes, playing essential roles in the structure and function of cells. Based on their location and function, membrane proteins can be classified into three main categories: peripheral membrane proteins, integral membrane proteins, and lipid-anchored proteins. Membrane proteins encompass a variety of functional proteins, including glycoproteins, carrier proteins, and enzymes. They are often linked to carbohydrate molecules, which can transmit signals into the cell by undergoing structural changes, participating in signal transduction processes. Membrane proteins perform a range of critical functions, including substance transport, signal transduction, cell recognition, and energy conversion. In drug development, membrane proteins, especially G protein-coupled receptors (GPCRs), ion channels, and transporters, are of particular interest. Many diseases are related to the malfunction of specific membrane proteins. Therefore, drugs designed to target these proteins can regulate their activity, aiming to treat diseases. TargetMol has collected 6422 compounds that target membrane proteins, which can be used for membrane protein-related scientific research and drug screening, suitable for high-throughput and high-content screening.

A unique collection of 1920 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 573 cancer cell differentiation inducing compounds for high throughput and high content screening;

97 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.